Henry Pertinez

1.5k total citations
31 papers, 495 citations indexed

About

Henry Pertinez is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Henry Pertinez has authored 31 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Henry Pertinez's work include Tuberculosis Research and Epidemiology (14 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Henry Pertinez is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Henry Pertinez collaborates with scholars based in United Kingdom, United States and Netherlands. Henry Pertinez's co-authors include Geraint Davies, Leon Aarons, Kayode Ogungbenro, Charles A. Peloquin, Yanmin Hu, Saye Khoo, Anthony Coates, Yingjun Liu, Jan‐Willem C. Alffenaar and Andrew Owen and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Henry Pertinez

26 papers receiving 487 citations

Peers

Henry Pertinez

EPIDE

PHARM

R.E. Aarnoutse Netherlands

Pierre Comby France

Araz Raoof Belgium

Ryuji Kubota Japan

Allen Moton United States

Gary D. Bowers United States

Thomas Mercier Switzerland

Aurélie Barrail‐Tran France

Dennis H. Giesing United States

S. J. Roffey United Kingdom

R.E. Aarnoutse Netherlands

Henry Pertinez

375 ×1.5

182 ×1.2

EPIDE

113 ×1.1

PHARM

55 ×0.6

PHARM

87 ×0.9

Citations per year, relative to Henry Pertinez Henry Pertinez (= 1×) peers R.E. Aarnoutse

Countries citing papers authored by Henry Pertinez

Since Specialization

Citations

This map shows the geographic impact of Henry Pertinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Pertinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Pertinez more than expected).

Fields of papers citing papers by Henry Pertinez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Pertinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Pertinez. The network helps show where Henry Pertinez may publish in the future.

Co-authorship network of co-authors of Henry Pertinez

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Pertinez. A scholar is included among the top collaborators of Henry Pertinez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Pertinez. Henry Pertinez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Platt, Georgina, Charles A. Peloquin, Julia Coit, et al.. (2025). Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial. The Journal of Infectious Diseases. 232(2). e258–e265.

Tatham, Lee, Anja Kipar, Joanne Sharp, et al.. (2024). Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case. Microbiology Spectrum. 12(8). e0391623–e0391623.

Manosuthi, Weerawat, Henry Pertinez, Andrew Owen, et al.. (2024). Favipiravir pharmacokinetics in Thai adults with mild COVID‐19: A sub‐study of interpatient variability and ethnic differences in exposure. Pharmacology Research & Perspectives. 12(6). e1233–e1233.

Lamorde, Mohammed, et al.. (2024). Population pharmacokinetic modeling of paired plasma–breast milk lamivudine data for estimation of infant exposure in breastfeeding mother–infant pairs. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1978–1989. 2 indexed citations

Gallardo‐Toledo, Eduardo, Megan Neary, Joanne Sharp, et al.. (2023). Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses. 15(11). 2161–2161.

Rajoli, Rajith K. R., Henry Pertinez, Lalitkumar K. Vora, et al.. (2023). Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans. Pharmaceutics. 15(12). 2709–2709. 5 indexed citations

Curley, Paul, Neill J. Liptrott, Edward Makarov, et al.. (2023). Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics. 15(7). 1835–1835. 3 indexed citations

Neary, Megan, Usman Arshad, Lee Tatham, et al.. (2023). Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. Journal of Chromatography B. 1228. 123823–123823. 4 indexed citations

Pertinez, Henry, Jamilah Meghji, Elizabeth L. Corbett, et al.. (2022). High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis. Clinical Infectious Diseases. 75(9). 1520–1528. 5 indexed citations

10.

Arshad, Usman, Henry Pertinez, Helen Box, et al.. (2021). Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Nanoscale. 13(13). 6410–6416. 14 indexed citations

11.

Pertinez, Henry, Rajith K. R. Rajoli, Saye Khoo, & Andrew Owen. (2021). Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2. Journal of Antimicrobial Chemotherapy. 76(8). 2121–2128. 18 indexed citations

12.

Millard, James, Henry Pertinez, Laura Bonnett, et al.. (2018). Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation. Journal of Antimicrobial Chemotherapy. 73(7). 1755–1762. 27 indexed citations

13.

Velásquez, Gustavo E., Meredith B. Brooks, Julia Coit, et al.. (2018). Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 657–666. 74 indexed citations

14.

Knegt, Gerjo J. de, Laura Dickinson, Henry Pertinez, et al.. (2017). Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model. Tuberculosis. 105. 113–118. 13 indexed citations

15.

Hu, Yanmin, Henry Pertinez, Fátima Ortega-Muro, et al.. (2016). Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model. Antimicrobial Agents and Chemotherapy. 60(8). 4778–4785. 17 indexed citations

16.

Ogungbenro, Kayode, Henry Pertinez, & Leon Aarons. (2014). Empirical and Semi-Mechanistic Modelling of Double-Peaked Pharmacokinetic Profile Phenomenon Due to Gastric Emptying. The AAPS Journal. 17(1). 227–236. 26 indexed citations

17.

Pertinez, Henry, Marylore Chenel, & Leon Aarons. (2013). A Physiologically Based Pharmacokinetic Model for Strontium Exposure in Rat. Pharmaceutical Research. 30(6). 1536–1552. 12 indexed citations

18.

Burt, Howard, Henry Pertinez, Claire Collins, et al.. (2012). Progress Curve Mechanistic Modeling Approach for Assessing Time-Dependent Inhibition of CYP3A4. Drug Metabolism and Disposition. 40(9). 1658–1667. 14 indexed citations

19.

Jones, Hannah M., Iain Gardner, Wendy T. Collard, et al.. (2011). Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling. Clinical Pharmacokinetics. 50(5). 331–347. 79 indexed citations

20.

Benson, Neil, Joost de Jongh, Hannah M. Jones, et al.. (2009). Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice. Antimicrobial Agents and Chemotherapy. 54(3). 1179–1185. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact